Metraipolis › archive › dc_17dc9816702d

Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41200848
DOI
10.1111/pai.70196
License (as archived)
solo-consultazione
Archived
2026-11-08T20:49:58.660Z
SHA-256 of the archived text
6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea
Stable URL of this page
https://metraipolis.com/documento/dc_17dc9816702d

How to cite

Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848 — Europe PMC (en), https://europepmc.org/article/MED/41200848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17dc9816702d (Metraipolis archive dc_17dc9816702d, sha256 6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea)
BibTeX
@misc{dc17dc9816702d,
  title = {Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41200848},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17dc9816702d; sha256 6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41200848. Agents can read the archived copy with the MCP tool read_document.